×

France Recommends AstraZeneca Vaccine For 55 And Above

    Advertisement France’s health authority on Friday recommended that only people aged 55 and over should be given the AstraZeneca Covid-19 vaccine due to … Continue reading France Recommends AstraZeneca Vaccine For 55 And Above


In this file photo taken on March 12, 2021 shows empty vials of the AstraZeneca Covid-19 vaccine at a vaccination center at the UBO (Universite Bretagne Occidentale) in Brest, western France. The Netherlands suspends the use of AstraZeneca vaccine on March 14, 2021. Fred TANNEAU / AFP
This file photo taken on March 12, 2021, shows empty vials of the AstraZeneca Covid-19 vaccine at a vaccination center at the UBO (Universite Bretagne Occidentale) in Brest, western France.
The Netherlands suspends the use of AstraZeneca vaccine on March 14, 2021.
Fred TANNEAU / AFP

 

 

France’s health authority on Friday recommended that only people aged 55 and over should be given the AstraZeneca Covid-19 vaccine due to reports of blood clots while giving the green light to resume its use after a brief suspension.

It said its recommendation was based on the fact that the reports of blood clots that had prompted its suspension in France and other European countries had only been seen in those aged under 55.

In this file photo taken on February 12, 2021 a vial containing the Covid-19 vaccine by AstraZeneca and a syringe are seen on a table in the pharmacy of the vaccination center at the Robert Bosch hospital in Stuttgart, southern Germany. Danish health authorities said on March 11, 2021 they were temporarily suspending the use of AstraZeneca’s Covid-19 vaccine as a precaution after some patients developed blood clots since receiving the jab. The move comes “following reports of serious cases of blood clots among people vaccinated with AstraZeneca’s Covid-19 vaccine”, the Danish Health Authority said in a statement.
THOMAS KIENZLE / AFP

 

Prime Minister Jean Castex, himself aged 55, is due to be given the vaccine later Friday to boost confidence in the jab after the European medicine watchdog ruled it was safe to use.